MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

First test to screen blood donations for Zika virus wins FDA nod

October 6, 2017 By Sarah Faulkner Leave a Comment

The FDA today approved Roche Molecular System‘s (OTC:RHHBY) cobas Zika test, which detects Zika virus RNA in plasma specimens collected from volunteer blood donors and living organ donors. The test is designed to be used by blood collection establishments to detect Zika virus in blood donations – not for the diagnosis of Zika virus infection in […]

Filed Under: Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Roche

FDA taps Apple, J&J and others for health software pre-cert pilot

September 27, 2017 By Sarah Faulkner Leave a Comment

The FDA yesterday named the nine companies that will be included in a pilot program to pre-certify healthcare software developers. The program was designed with the hopes of reducing the amount of information the regulatory watchdog requires for review. The companies include Apple (NSDQ:AAPL), Fitbit (NYSE:FIT), Johnson & Johnson (NYSE:JNJ), Pear Therapeutics, Phosphorus, Roche (OTC:RHHBY), Samsung, Tidepool and Verily. […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: Apple, Fitbit, Johnson and Johnson, peartherapeutics, phosphorus, Roche, samsung, Tidepool, Verily

UK warns about alarm failure for Roche’s insulin pumps

September 20, 2017 By Sarah Faulkner Leave a Comment

The UK’s Medicines and Healthcare products Regulatory Agency issued a medical device alert for Roche‘s (OTC:RHHBY) Accu-Check Insight insulin pumps today, warning that the device’s audible and vibration alarms may not function. If a user doesn’t see the notification message on the pump and can’t hear or feel an alarm, it could lead to hyperglycemia, the agency said. […]

Filed Under: Drug Pumps, Drug-Device Combinations, Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Roche, Roche Diabetes Care

Novartis CEO departs, leaving corner office to Harvard doc

September 5, 2017 By Sarah Faulkner Leave a Comment

Novartis‘ (NYSE:NVS) chief executive Joseph Jimenez is slated to leave his post next February, the drugmaker reported over the weekend. The CEO’s surprise departure leaves the corner office to Dr. Vasant Narasimhan, who currently serves as the company’s CMO and global head of drug development. The move comes just days after Novartis won FDA approval for […]

Filed Under: Business/Financial News, Pharmaceutical, Wall Street Beat Tagged With: GlaxoSmithKline plc, Novartis, Roche

House Dems launch MS drug pricing probe

August 17, 2017 By Sarah Faulkner Leave a Comment

Democrats from the House Committee on Oversight and Government Reform have sent letters to seven drugmakers as part of an investigation into why prices for multiple sclerosis drugs have nearly quadrupled since 2004. Reps. Elijah Cummings (D-Md.) and Peter Welch (D-Mass.) penned inquiries to Bayer, Biogen, EMD Serono, Novartis, Roche, Sanofi-Aventis and Teva Pharmaceuticals. Get […]

Filed Under: Legal News, Pharmaceutical, Wall Street Beat Tagged With: Bayer, Biogen, Capitol Hill, Novartis, Roche, Sanofi-Aventis, Teva Pharmaceuticals

Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing

August 16, 2017 By Sarah Faulkner Leave a Comment

Mimetas said today that it collaborated with Roche (OTC:RHHBY) to develop an organ-on-a-chip system that is designed to evaluate intestinal permeability in 3D gut tubules following exposure to drug compounds using the 10 panel drug tests. The results of the collaboration were published in Nature Communications. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Pharmaceutical, Research & Development Tagged With: mimetas, Roche

Roche taps Accenture’s analytics tech for digital diabetes management

July 26, 2017 By Sarah Faulkner Leave a Comment

Accenture (NYSE:ACN) said today that it inked a five-year deal with Roche (OTC:RHHBY) to incorporate its analytics platform into Roche’s digital diabetes management system. According to the deal, Roche’s new digital “diabetes ecosystem” will be built on the Accenture Intelligent Patient Platform. The system reportedly allows Roche to collect and analyze data from diabetes patients in the […]

Filed Under: Big Data, Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Accenture plc., Roche

Roche buys mySugr diabetes app

June 30, 2017 By Sarah Faulkner Leave a Comment

Swiss drugmaker Roche (PINK:RHHBY) said today that it bought diabetes management platform mySugr for an undisclosed price. The 2 companies have worked together since 2014. mySugr’s digital tech enables users to track things like their blood sugar, diabetes medications and physical activity. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Diabetes, Health Information Technology, Patient Monitoring, Pharmaceutical, Wall Street Beat Tagged With: Roche

Novartis trial results could spell trouble for Regeneron

June 21, 2017 By Sarah Faulkner Leave a Comment

Head-to-head late-stage clinical trials published on Tuesday showed that a Novartis (NYSE:NVS) drug to treat patients with neovascular age-related macular degeneration doesn’t need to be injected as frequently as a rival drug from competitor Regeneron (NSDQ:REGN). Analysts reportedly said the data gives Novartis’ treatment, RTH258, a competitive edge compared to its rival therapies. Get the full […]

Filed Under: Clinical Trials, Optical/Ophthalmic, Pharmaceutical, Wall Street Beat Tagged With: Allergan, Novartis, Regeneron, Roche

Pieris, AstraZeneca ink $45m deal for inhaled respiratory drugs

May 3, 2017 By Sarah Faulkner Leave a Comment

Pieris Pharmaceuticals (NSDQ:PIRS) inked a $45 million deal with AstraZeneca (NYSE:AZN) to develop a group of inhaled drugs for respiratory diseases. According to the deal, Pieris will get $45 million up front to bring an experimental asthma drug into human clinical trials. The drug is slated to begin Phase I testing this year, which will […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Respiratory, Wall Street Beat Tagged With: Allergan, AstraZeneca plc, pierispharmaceuticals, Roche

Roche warns on bolus advisor issues with Accu-Check Connect app

April 11, 2017 By Fink Densford Leave a Comment

Roche (PINK:RHHBY) this week warned of potential issues with its Accu-Check Connect diabetes management application which could lead the app to provide inaccurate bolus insulin recommendations. The Swiss company said it recently discovered a software bug in its Accu-Check Connect diabetes management app versions 2.0.0, 2.0.1 and 2.1.0 for Apple (NSDQ:AAPL) iOS and Google (NSDQ:GOOG) Android […]

Filed Under: Diabetes, Software / IT Tagged With: Roche

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS